BB Biotech AG
BION.SW
$0.34
Change (1 day)
$56.39
Year High
$40.14
Year Low
Categories
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Earnings for BB Biotech AG (BION.SW)
Earnings in 2023 (TTM): $-233,846,934
According to BB Biotech AG's latest financial reports the company's current earnings (TTM) are $-233,846,934. The earnings displayed on this page is the company's Pretax Income.
Earnings history of BB Biotech AG
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-233,846,934 | $-233,936,384 |
| 2022 | $-405,073,281 | $-405,142,350 |
| 2021 | $-458,278,984 | $-458,354,847 |
| 2020 | $782.69 M | $782.6 M |
| 2019 | $767.12 M | $767.04 M |
| 2018 | $-533,610,515 | $-533,690,906 |
| 2017 | $778.53 M | $778.44 M |
| 2016 | $-908,079,477 | $-908,159,868 |
| 2015 | $739.26 M | $739.17 M |
| 2014 | $1.66 B | $1.66 B |
| 2013 | $1.06 B | $1.06 B |
| 2012 | $416.83 M | $416.49 M |
| 2011 | $-73,655,761 | $-73,754,269 |
| 2010 | $-165,645,353 | $-165,706,496 |
| 2009 | $42.38 M | $41.47 M |
| 2008 | $51.42 M | $51.35 M |
| 2007 | $-300,390,862 | $-300,518,809 |
| 2006 | $336.86 M | $336.73 M |
| 2005 | $360.26 M | $360.06 M |
| 2004 | $229.68 M | $229.57 M |
| 2003 | $203.25 M | $203.06 M |